Decreased levels of ANGPTL4—coding for angiopoietin-like protein 4, which regulates lipid and glucose metabolism and the growth of new blood vessels—could lead to inhibition of angiogenesis in cancer cells. Here, ANGPTL4 is linked to cancer.